SAVE MONEY ON TRAVEL DEALS

Researchers at the University of Michigan said they used computer models to develop a compound that inhibits the HIV protease -- an enzyme that promotes the replication of the virus. The scientists said their achievement might lead to a new class of AIDS drugs.

The study's principal investigator, Professor Heather Carlson, stressed the finding is only a preliminary, yet significant, step.

"It's very easy to make an inhibitor, (but) it's very hard to make a drug", said Carlson. "This compound is too weak to work in the human body. The key is to find more compounds that will work by the same mechanism."

The study appeared in the March 31 online edition of the journal Biopolymers.

 BREAKING STORIES

Circumcision plan rejected by Kenyans

Health officials cancel HIV vaccine trial

Scientist study genetic variants and HIV

Scientist think they've found HIV weakness

HIV-positive man guilty of uninformed sex

Activists target HIV-related human rights

Team 'turns off' genes to fight bird flu

Senate, House to adjourn Sept. 26

Bush calls G8 summit 'success'

G8 countries reaffirm pledges to Africa

Infant formula blocks HIV transmission

Aiken visits Somalia for UNICEF

Study might lead to new AIDS treatment

Bush: Time for G8 to 'write checks'

HIV 5-year death rate has decreased

Bush presses for renewal of aid to Africa

STDs doubled in Britain among middle-aged

Sex partners link trust with low STD risk

Elton John ball filled with jewels, celebs

Winehouse performs at Mandela concert